17-OH-Progesterone RIA (CT)
- Regulatory Status
- EU: CE
- Kit size
- 96
- Method
- RIA (CT)
- Incubation time
- 1 x 3 h
- Standard range
- 0.17 - 14 ng/mL
- Specimen / Volumes
- 25 µL serum, plasma
- Substrate / isotope
- 125I < 190 kBq
Radioimmunoassay for the quantitative determination of 17-OH-Progesterone in human serum and plasma.
Biological activities of 17-hydroxyprogesterone
17α-hydroxyprogesterone (17-OHP) is a C-21 steroid hormone (molecular weight 330.3) which is produced from 17α-hydroxypregnenolone in the adrenals and also in the ovaries, testes and placenta. 17-OHP is hydroxylated at positions 11 and 21 to produce cortisol via 11-deoxycortisol.
Clinical applications of 17α-hydroxyprogesterone determination
As a rule, serum or amniotic fluid 17-OHP dosages are relevant to diagnose congenital adrenal hyperplasia (CAH).
This CAH is due to a specific enzyme defect (six distinct enzyme deficiencies have been described). As a result of these deficiencies, ACTH increases and produces adrenal hyperplasia and the raise of many steroid precursors. But it is also very interesting to know the value of 17-OHP in patients with varicocele. (17-OHP and testosterone represent markers of Leydig cell function) and in ageing male patients to detect Benign Prostatic Hypertrophy (BPH) and carcinoma of the prostate (PCA) (plasma 17-OHP is significantly lower in PCA and BPH groups than in normal men). There are other domains for 17-OHP investigations as: male infertility, girls with peripubertal virilization, children with premature adrenache (in these cases, the values of 17-OHP are increased without or after ACTH stimulation)
For concrete data please consult the Instruction for Use in the download box on the top right side.
Our comprehensive immunoassay portfolio includes a number of specialty diagnostic immunoassays for endocrinology, immunology and autoimmunity, as well as for diagnosis of multiple infectious diseases. We are pioneers and market leaders in saliva diagnostics, with over 40 years of experience supplying a broad portfolio of luminescence- and ELISA-based tests, including our highly acclaimed HMGB1 and MuSK-Ab ELISAs.
And as experts in laboratory automation, we can support our customers with the protocols for open ELISA platforms, such as the Freedom EVOlyzer or Thunderbolt®.
All products are only available for sale to laboratory professionals and may not be available in all countries. Availability and regulatory status may vary across regions depending on local country-specific registration. Please always read and follow the instructions for use.
All of our assays have been designed and manufactured to meet the highest global regulatory requirements and quality standards. Tecan is certified under ISO 9001:2015, ISO 13485:2016 and is audited by a notified body according to Medical Device Single Audit Program (MDSAP).

As part of the Tecan Group, we have a leading market position in diagnostics and research, with over 40 years of experience in the development, manufacture and supply of enzyme-, radiolabel- and luminescence-based immunoassays.
Our range of high-quality immunoassays is supported by a diverse portfolio of automated solutions, making us the perfect partner for you and your customers.
At Tecan, we are driven to improve people’s lives and health.